To evaluate the risk of major thromboembolic complications in male germ cell cancer patients receiving cisplatin-based chemotherapy and to review the literature on this subject.
Departments of Clinical Oncology, Medical Statistics, and Clinical Epidemiology, and Hemostasis and Thrombosis Research Center, Leiden University Medical Center, Leiden, the Netherlands.